Edward A. Stadtmauer

faculty photo
Professor of Medicine at the Hospital of the University of Pennsylvania
Co-Leader, Hematologic Malignancies Program, University of Pennsylvania Abramson Cancer Center
Co-Leader, Hematologic Malignancies Translational Center of Excellence, Penn Medicine/Abramson Cancer Center
Chief, Section of Hematologic Malignancies, Division of Hematology-Oncology, Department of Medicine
Department: Medicine

Contact information
2 Perelman Center for Advanced Medicine
34th and Civic Center Bld
2-319S
Philadelphia, PA 19104
Office: 2156627910
Fax: 215-662-4064
Education:
A.B. (Biochemistry)
Cornell University, College of Arts and Sciences, 1979.
M.D. (Medicine)
University of Pennsylvania School of Medicine, 1983.
Permanent link
 

Description of Research Expertise

Clinical trials, Bone Marrow Transplant

Description of Itmat Expertise

Dr. Stadtmauer is pursuing new treatment approaches to improve the long term survival of patients with leukemia, lymphoma, myeloma and those undergoing bone marrow transplant.

Selected Publications

Garfall, Alfred L; Maus, Marcela V; Hwang, Wei-Ting; Lacey, Simon F; Mahnke, Yolanda D; Melenhorst, J Joseph; Zheng, Zhaohui; Vogl, Dan T; Cohen, Adam D; Weiss, Brendan M; Dengel, Karen; Kerr, Naseem D S; Bagg, Adam; Levine, Bruce L; June, Carl H; Stadtmauer, Edward A.: Chimeric Antigen Receptor T Cells against CD19 for Multiple Myeloma. New England Journal of Medicine 373(11): 1040-7, Sep 10 2015.

Rapoport, Aaron P; Stadtmauer, Edward A; Binder-Scholl, Gwendolyn K; Goloubeva, Olga; Vogl, Dan T; Lacey, Simon F; Badros, Ashraf Z; Garfall, Alfred; Weiss, Brendan; Finklestein, Jeffrey; Kulikovskaya, Irina; Sinha, Sanjoy K; Kronsberg, Shari; Gupta, Minnal; Bond, Sarah; Melchiori, Luca; Brewer, Joanna E; Bennett, Alan D; Gerry, Andrew B; Pumphrey, Nicholas J; Williams, Daniel; Tayton-Martin, Helen K; Ribeiro, Lilliam; Holdich, Tom; Yanovich, Saul; Hardy, Nancy; Yared, Jean; Kerr, Naseem; Philip, Sunita; Westphal, Sandra; Siegel, Don L; Levine, Bruce L; Jakobsen, Bent K; Kalos, Michael; June, Carl H.: NY-ESO-1-specific TCR-engineered T cells mediate sustained antigen-specific antitumor effects in myeloma. Nature Medicine 21(8): 914-21, Aug 2015.

Waxman, A J; Mick, R; Garfall, A L; Cohen, A; Vogl, D T; Stadtmauer, E A; Weiss, B M.: Classifying ultra-high risk smoldering myeloma. Leukemia 29(3): 751-3, Mar 2015.

Frosch, Zachary; Luskin, Marlise R; Landsburg, Daniel J; Schuster, Stephen J; Svoboda, Jakub; Loren, Alison W; Porter, David L; Stadtmauer, Edward A; Nasta, Sunita D.: R-CHOP or R-HyperCVAD with or without autologous stem cell transplantation for older patients with mantle cell lymphoma. Clinical lymphoma, myeloma & leukemia 15(2): 92-7, Feb 2015.

Freytes, Cesar O; Toro, Juan J; Yeh, Rosa F; Stadtmauer, Edward A; Ratanatharathorn, Voravit; Akpek, Gorgun; Sahovic, Entezam; Tricot, Guido J; Shaughnessy, Paul J; White, Darrell J; Rodriguez, Tulio E; Solomon, Scott R; Yu, Louie H; Zhao, Cathy; Patil, Shiva; Armstrong, Elizabeth; Smith, Angela; Elekes, Agnes; Kato, Kazunobu; Reece, Donna E.: Safety and efficacy of targeted-dose busulfan and bortezomib as a conditioning regimen for patients with relapsed multiple myeloma undergoing a second autologous blood progenitor cell transplantation. Biology of Blood & Marrow Transplantation 20(12): 1949-57, Dec 2014.

Landsburg, Daniel J; Vogl, Dan T; Plastaras, John P; Stadtmauer, Edward A.: Melphalan/total body irradiation-conditioned myeloablative allogeneic hematopoietic cell transplantation for patients with primary plasma cell leukemia. Clinical lymphoma, myeloma & leukemia 14(6): e225-8, Dec 2014.

Stadtmauer, Edward A; Sullivan, Keith M; Marty, Francisco M; Dadwal, Sanjeet S; Papanicolaou, Genovefa A; Shea, Thomas C; Mossad, Sherif B; Andreadis, Charalambos; Young, Jo-Anne H; Buadi, Francis K; El Idrissi, Mohamed; Heineman, Thomas C; Berkowitz, Elchonon M.: A phase 1/2 study of an adjuvanted varicella-zoster virus subunit vaccine in autologous hematopoietic cell transplant recipients. Blood 124(19): 2921-9, Nov 6 2014.

Garfall, A L; Dougherty, A L; Vogl, D T; Weiss, B M; Cohen, A D; Mick, R; O'Doherty, U; Stadtmauer, E A.: Association between mobilization regimen and PFS after auto-SCT for multiple myeloma. Bone Marrow Transplantation 49(11): 1439-41, Nov 2014.

Reshef, Ran; Hexner, Elizabeth O; Loren, Alison W; Frey, Noelle V; Stadtmauer, Edward A; Luger, Selina M; Mangan, James K; Gill, Saar I; Vassilev, Pavel; Lafferty, Kathryn A; Smith, Jacqueline; Van Deerlin, Vivianna M; Mick, Rosemarie; Porter, David L.: Early donor chimerism levels predict relapse and survival after allogeneic stem cell transplantation with reduced-intensity conditioning. Biology of Blood & Marrow Transplantation 20(11): 1758-66, Nov 2014.

Alsina, Melissa; Becker, Pamela S; Zhong, Xiaobo; Adams, Alexia; Hari, Parameswaran; Rowley, Scott; Stadtmauer, Edward A; Vesole, David H; Logan, Brent; Weisdorf, Daniel; Qazilbash, Muzaffar; Popplewell, Leslie L; McClune, Brian; Bensinger, William; Riches, Marcie; Giralt, Sergio A; Pasquini, Marcelo C; Resource for Clinical Investigation in Blood and Marrow Transplantation.: Lenalidomide maintenance for high-risk multiple myeloma after allogeneic hematopoietic cell transplantation. Biology of Blood & Marrow Transplantation 20(8): 1183-9, Aug 2014.

back to top
Last updated: 11/18/2015
The Trustees of the University of Pennsylvania